Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical and Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical and Vaccines. This report contains market size and forecasts of Biopharmaceutical and Vaccines in global, including the following market information:
- Global Biopharmaceutical and Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Biopharmaceutical and Vaccines market was valued at US$ 55.44 billion in 2022 and is projected to reach US$ 61.04 billion by 2029, at a CAGR of 11.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biopharmaceutical Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceutical and Vaccines include Novartis, Pfizer, Sanofi, Roche, Abbott, Biogen Idec, Regeneron Pharmaceuticals, Alexion Pharmaceuticals and Johnson and Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biopharmaceutical and Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceutical and Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceutical and Vaccines Market Segment Percentages, by Type, 2022 (%)
- Biopharmaceutical
- Vaccine Production
Global Biopharmaceutical and Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceutical and Vaccines Market Segment Percentages, by Application, 2022 (%)
- Pharmaceuticals Industry
- Clinical Diagnosis
- Scientific Research
- Others
Global Biopharmaceutical and Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biopharmaceutical and Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biopharmaceutical and Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Biopharmaceutical and Vaccines revenues share in global market, 2022 (%)
key players include:
- Novartis
- Pfizer
- Sanofi
- Roche
- Abbott
- Biogen Idec
- Regeneron Pharmaceuticals
- Alexion Pharmaceuticals
- Johnson and Johnson
- GlaxoSmithKline
- Merck
- Lonza
- Boehringer Ingelheim
- Rentschler
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Biopharmaceutical and Vaccines, market overview.
- Chapter 2: Global Biopharmaceutical and Vaccines market size in revenue.
- Chapter 3: Detailed analysis of Biopharmaceutical and Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Biopharmaceutical and Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
